Medical Collagen Market Size & Share Report 2022, 2028
预计医用胶原蛋白市场规模将从 2020 年的 5.937 亿美元增至 2028 年的 9.574 亿美元;预计2021 年至 2028 年的复合年增长率为 6.2% 。
胶原蛋白是人体内含量最丰富的蛋白质。它主要存在于韧带、皮肤、肌腱、角膜、血管、骨骼、软骨和 椎间盘等纤维组织中。医用胶原蛋白是一种具有低免疫原性的生物相容性材料。胶原蛋白具有良好的止血性能并有助于伤口愈合。它用于细胞培养,因为它支持晶格结构和细胞结合域中的细胞增殖。医用胶原蛋白广泛用于伤口愈合、组织工程、重建手术、骨移植和整容手术等应用。医用胶原蛋白市场的增长归因于胶原蛋白在医疗行业的应用不断增加以及 FDA 批准和产品发布的不断增加等因素。然而,产品召回阻碍了市场的增长。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
医用胶原蛋白市场:
Medical Collagen Market: Strategic Insights
Medical Collagen Market
-
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cagr.png)
CAGR (2020 - 2028)
6.2%
-
Market Size 2020
US$ 593.7 Million
-
Market Size 2028
US$ 957.4 Million
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- DSM
- INTEGRA LIFESCIENCES CORPORATION
- COLLAGEN MATRIX, INC.
- ENCOLL
- COLLAGEN SOLUTIONS PLC
- INNOCOLL
- SYMATESE
- GELITA AG
- COLLPLANT BIOTECHNOLOGIES LTD
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
来源(牛、猪及其他)
产品(明胶、水解胶原蛋白、天然胶原蛋白等)
应用(伤口护理、骨移植、组织支架、软骨修复、止血剂、诊断、血管移植等)
Medical Collagen Market: Strategic Insights
-
CAGR (2020 - 2028)6.2% -
Market Size 2020
US$ 593.7 Million -
Market Size 2028
US$ 957.4 Million
![](https://www.theinsightpartners.com/assets/images/rd_int_img/tip-logo.jpg)
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- DSM
- INTEGRA LIFESCIENCES CORPORATION
- COLLAGEN MATRIX, INC.
- ENCOLL
- COLLAGEN SOLUTIONS PLC
- INNOCOLL
- SYMATESE
- GELITA AG
- COLLPLANT BIOTECHNOLOGIES LTD
Regional Overview
![](https://www.theinsightpartners.com/assets/images/rd_int_img/ig-regional.png)
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_danger.png)
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_warning.png)
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_primary.png)
复合年增长率(2020 - 2028 年)6.2%- 2020 年市场规模
5.937 亿美元 - 2028 年市场规模
9.574 亿美元
![](https://www.theinsightpartners.com/assets/images/rd_int_img/tip-logo.jpg)
市场动态
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
关键人物;主力;重要一员
- 帝斯曼
- INTEGRA 生命科学公司
- 胶原蛋白基质公司
- 恩科尔
- 胶原蛋白解决方案有限公司
- 英诺柯尔
- 叙马提亚人
- 嘉利达公司
- COLLPLANT 生物技术有限公司
区域概况
![](https://www.theinsightpartners.com/assets/images/rd_int_img/ig-regional.png)
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_danger.png)
- 牛
- 猪
- 其他的
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_warning.png)
- 明胶
- 水解胶原蛋白
- 天然胶原蛋白
- 其他的
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_primary.png)
- 伤口护理
- 骨移植
- 组织支架
- 软骨修复
- 止血剂
- 诊断
- 血管移植
- 其他的
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
报告范围
市场洞察
胶原蛋白在医疗行业的应用日益广泛
胶原蛋白是人体结缔组织中发现的蛋白质。它是哺乳动物中最丰富的蛋白质,约占全身蛋白质含量的 25%–35%。由于胶原蛋白抗原性弱且可生物降解,因此具有出色的生物相容性。因此,它成为医疗应用的主要资源。
心脏细胞外基质 (ECM) 由纤维胶原蛋白组成,它提供力量传递方式,保持心肌完整性,并支持肌细胞几何形状。多项研究证明,服用胶原蛋白补充剂有助于降低患心脏相关疾病的风险。
胶原蛋白是化妆品配方中的关键成分之一,因为它具有保湿、再生和成膜特性。胶原蛋白具有出色的结合水的能力,有助于全天保持皮肤中适当的水分含量,从而使皮肤保持湿润和柔软。此外,胶原蛋白填充剂在美容医学中得到广泛应用。皮下注射可溶性胶原蛋白可提高皮肤的质量和密度,从而修复皮肤病学缺陷。
胶原基生物材料在体内和体外具有广泛的应用。胶原蛋白已被广泛用于开发脊柱、四肢和牙齿的合成骨移植替代品。此外,胶原蛋白支架被开发用于模拟和再生天然组织,并正在迅速用于软骨修复。
胶原蛋白自然参与伤口愈合过程,使用基于胶原蛋白的伤口敷料可为急性和慢性伤口闭合提供多种优势。此外,胶原蛋白敷料可以通过吸收或提供水分来控制伤口的湿度。因此,胶原蛋白被广泛用于敷料、颗粒和可流动支架中,以治疗急性和慢性伤口。
胶原蛋白在医疗行业的广泛应用有利于市场的增长。
基于产品的洞察
医用胶原蛋白市场按来源分为牛胶原蛋白、猪胶原蛋白和其他胶原蛋白。2020 年,牛胶原蛋白占据了最大的市场份额,预计在预测期内,牛胶原蛋白的复合年增长率最高。
基于产品的洞察
根据产品,医用胶原蛋白市场分为明胶、水解胶原蛋白、天然胶原蛋白等。明胶部分在 2020 年占据了最大的市场份额,预计在预测期内将实现市场最高复合年增长率。
基于应用的洞察
根据应用,医用胶原蛋白市场细分为止血剂、血管移植物、组织支架、软骨修复、伤口护理、骨移植、诊断等。伤口护理部分在 2020 年占据了最大的市场份额,而骨移植部分预计在预测期内将实现市场上最高的复合年增长率。
产品发布和审批是企业扩大全球业务和产品组合的常用策略。合作是医用胶原蛋白市场参与者扩大全球客户群的主要策略之一,这反过来又使他们能够在全球范围内维护自己的品牌。
医用胶原蛋白市场报告范围
报告属性 | 细节 |
---|---|
2020 年市场规模 | 5.937 亿美元 |
2028 年市场规模 | 9.574 亿美元 |
全球复合年增长率(2020 - 2028) | 6.2% |
历史数据 | 2018-2019 |
预测期 | 2021-2028 |
涵盖的领域 | 按来源
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
医用胶原蛋白市场 – 按来源
- 牛
- 猪
- 其他的
医用胶原蛋白市场 – 按产品分类
- 明胶
- 水解胶原蛋白
- 天然胶原蛋白
- 其他的
医用胶原蛋白市场 – 按应用
- 伤口护理
- 骨移植
- 组织支架
- 软骨修复
- 止血剂
- 诊断
- 血管移植
- 其他
医用胶原蛋白市场 – 按地区划分
北美
- 我们
- 加拿大
- 墨西哥
欧洲
- 法国
- 德国
- 意大利
- 英国
- 西班牙
- 欧洲其他地区
亚太地区 (APAC)
- 中国
- 印度
- 韩国
- 日本
- 澳大利亚
- 亚太其他地区
中东和非洲 (MEA)
- 南非
- 沙特阿拉伯
- 阿联酋
- 中东和非洲其他地区
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地区
公司简介
- 帝斯曼
- Integra 生命科学公司
- 胶原蛋白基质公司
- 恩科尔
- 胶原蛋白解决方案有限公司
- 因诺科尔
- 叙马泰语
- 嘉利达公司
- Collplant 生物技术有限公司
- Croda International PLC。
Medical Collagen Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 593.7 Million |
Market Size by | US$ 957.4 Million |
Global CAGR | 6.2% |
Historical Data | 2018-2019 |
Forecast period | 2021-2028 |
Segments Covered |
By 来源(牛、猪及其他) |
Regions and Countries Covered |
北美(美国、加拿大、墨西哥)
|
Market leaders and key company profiles |
|
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
This text is related
to segments covered.
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The global medical collagen market growth is mainly attributed to factors such the rising applications of collagen in medical industry and growing FDA approvals and product launches fuel the growth of the market. However, product recalls is the major factor hindering the market growth.
The medical collagen market majorly consists of the players such as DSM, Integra Lifesciences Corporation, Collagen Matrix, Inc., Encoll, Collagen Solutions Plc, Innocoll, Symatese, Gelita Ag, Collplant Biotechnologies Ltd, and Croda Interntional PLC. among others.
Collagen is the most abundantly found protein in human body. It occurs mostly in fibrous tissues such as ligaments, skin, tendons, cornea, blood vessels, bones, cartilages, and intervertebral disc. Medical collagen is widely used in applications such as wound healing, tissue engineering, reconstructive surgeries, bone grafts, and cosmetic surgeries. It is bio-compatible material with low immunogenicity. Collagen has good hemostatic properties and facilitates wound healing. Collagen is used in cell cultures as it supports cell proliferation in lattice structures and cell binding domain. Hence collagen is widely used as a biomaterial in the medical industry. The exponential increase in number of regenerative surgeries performed on patients to treat certain forms of skin cancers, burn injuries, birth defects, and congenital diseases is primarily expected to drive the demand for medical collagen.
The List of Companies - Medical Collagen Market
- DSM
- INTEGRA LIFESCIENCES CORPORATION
- COLLAGEN MATRIX, INC.
- ENCOLL
- COLLAGEN SOLUTIONS PLC
- INNOCOLL
- SYMATESE
- GELITA AG
- COLLPLANT BIOTECHNOLOGIES LTD
- CRODA INTERNTIONAL PLC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.